Allergic rhinitis according to evidence-based medicine
https://doi.org/10.21518/2079-701X-2013-2-2-98-102
Abstract
Allergic rhinitis is one of the most common chronic diseases, affecting from 20 to 30% of adult population and 40% of children [8, 19]. In the past decades, the incidence of allergic rhinitis has been growing all over the world. 9% of the European population and 8.8 -16% of the U.S. population suffer from the pathology [1, 4]. Widespread comorbid conditions of allergic rhinitis which exacerbate the clinical pattern are asthma, sinusitis, otitis media [20, 24]. The disease is characterized by symptoms of different intensity which deteriorate the quality of life, everyday activity and productivity, even when treatment is quite effective [3, 14]. The main criteria in diagnosis of allergic rhinitis are medical history, clinical manifestations, positive skin tests and allergen-specific antibodies in blood serum.
About the Authors
V. S. Kozlov
Academic Medical Center of the Administrative Department of the President of the Russian Federation
Russian Federation
Russian Federation
l. L. Lazarevich
Academic Medical Center of the Administrative Department of the President of the Russian Federation
Russian Federation
Russian Federation
References
1. Basak O., Basak S., Gültekin B., Tekin N., Söylemez A. The prevalence of allergic rhinitis in adults in Aydin. Turkey // Rhinology. 2006. №44. Р. 283–287.
2. Bernstein D.I., Levy A.L., Hampel F.C., Baidoo C.A., Cook C.K., Philpot E.E., Rickard K.A. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis // Clin. Exp. Allergy. 2004. №34. Р. 952–957.
3. Canonica G.W., Bousquet J., Mullol J., Scadding G.K., Virchow J.C. A survey of the burden of allergic rhinitis in Europe // Allergy. 2007. №62 (Suppl. 85). Р. 17–25.
4. Desalu O.O., Salami A.K., Iseh K.R., Oluboyo P.O. Prevalence of self reported allergic rhinitis and its relationship with asthma among adult Nigerians // J. Investig. Allergol. Clin. Immunol. 2009. №19. Р. 474–480.
5. DeWester J., Philpot E.E., Westlund R.E., Cook C.K., Rickard K.A. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis // Allergy Asthma Proc. 2003. №24. Р. 331–337.
6. Gammeri E., Arena A., D'Anneo R., La Grutta S. Safety and tolerability of ultra-Rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma. Allergol Immunopathol (Madr). 2005 May–Jun. №33(3). Р. 142–144.
7. Gauchat J.F., Lebman D.A., Coffman R.L., Gascan H., de Vries J.E. Structure and expression of germline epsilon transcripts in human B cells induced by interleukin 4 to switch to IgE production // J. Exp. Med. 1990. №172. Р. 463–473.
8. Giavina-Bianchi P., Agondi R., Stelmach R., Cukier C., Kalil J. Fluticasone furoate nasal spray in the treatment of Allergic rhinitis // Ther. Clin. Risk. Manag. 2008. №4. Р. 465–472.
9. Lukat K.F., et al. A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled study // J. Asthma Allergy. 2013. №6. Р. 31–39.
10. Kim H., Kaplan A. Treatment and management of allergic rhinitis [feature] // Clinical Focus. 2008. Р. 1–4.
11. Lange B., Lukat K.F., Rettig K., Holtappels G., Bachert C. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis // Ann. Allergy Asthma Immunol. 2005. №95. Р. 272–282.
12. Leurs R., Church M.K., Taglialatela M. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects // Clin. Exp. Allergy. 2002. №32. Р. 489–498.
13. Lim M.Y., Leong J.L. Allergic rhinitis: evidence-based practice // Singapore Med. J. 2010. №51(7). Р. 542.
14. Marogna M., Faligiani P., Bruno M., Massolo A., Riva G. The allergic march in pollinosis: natural history and therapeutic implications // Int. Arch. Allergy Immunol. 2004. №135. Р. 336–342.
15. Onell A., Hjalle L., Borres P.M. Exploring the temporal development of childhood IgE profiles to allergen components // Clin. Transl. Allergy. 2012. №2. Р. 24.
16. Pawankar R., Yamagishi S., Yagi T. Revisiting the roles of mast cells in allergic rhinitis and its relation to local IgE synthesis // A.J. Rhinol. 2000. №14. Р. 309–317.
17. Portnoy J.M., Van Osdol T., Williams P.B. Evidence-based strategies or treatment of allergic rhinitis // Curr. Allergy Asthma Rep. 2004. №4. Р. 439–446.
18. Pullerits T., Praks L., Ristioja V., Lötvall J. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis // J. Allergy Clin. Immunol. 2002. №109. Р. 949–955.
19. Samolin´ski B., Sybilskia A., Raciborskia F., Tomaszewskaa A., Samel-Kowalika P., Walkiewicza A., et al. Prevalence of rhinitis in Polish population according to the ECAP (Epidemiology of Allergic Disorders in Poland) study // Otolaryngol. Pol. 2009. №63. Р. 324–330.
20. Shaaban R., Zureik M., Soussan D., Neukirch C., Heinrich J., Sunyer J., Wjst M., Cerveri I., Pin I., Bousquet J., Jarvis D., Burney P.G., Neukirch F., Leynaert B. Rhinitis and onset of asthma: a longitudinal population-based study // Lancet. 2008. №372. Р. 1049–1057.
21. Small P., Frenkiel S., Becker A., Boisvert P., Bouchard J.M.D., Carr S., Cockcroft D., Denburg J., Desrosiers M., Gall R., Hamid Q., Hébert J., Javer A., Keith P., Kim H., Lavigne F., Lemièr C., Massoud E., Payton K., Schellenberg B., Sussman G., Tannenbaum D., Watson W., Witterick I., Wright E. The Canadian Rhinitis Working Group. Rhinitis: A practical and comprehensive approach to assessment and therapy // J. Otolaryngol. 2007. №36 (Suppl. 1). S5–S27.
22. Takafuji S., Bischoff S.C., De Weck A.L., Dahinden C.A. Opposing effects of tumor necrosis factor-alpha and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N-formyl-methionyl-leucyl-phenylalanine // Eur. J. Immunol. 1992. №22. Р. 969–974.
23. Van Cauwenberge P., Bachert C., Passalacqua G., Bousquet J., Canonica G.W., Durham S.R., Fokkens W.J., Howarth P.H., Lund V., Malling H.J., Mygind N., Passali D., Scadding G.K., Wang D.Y. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology // Allergy. 2000. №55. Р. 116–134.
24. Virchow J.C., Kay S., Demoly P., Mullol J., Canonica W., Higgins V. Impact of ocular symptoms on quality of life (QoL), work productivity and resource utilisation in allergic rhinitis patients – an observational, cross sectional study in four countries in Europe // J. Med. Econ. 2011. №14. Р. 305–314.
25. Wachs M., Proud D., Lichtenstein L.M., et al. Observations on the pathogenesis of nasal priming // J. Allergy Clin. Immunol. 1989. №84. Р. 492–501.
26. Wallace D.V., Dykewicz M.S., Bernstein D.I., Blessing-Moore J., Cox L., Khan D.A., Lang D.M., Nicklas R.A., Oppenheimer J., Portnoy J.M., Randolph C.C., Schuller D., Spector S.L., Tilles S.A. The diagnosis and management of rhinitis: an updated practice parameter // J. Allergy Clin. Immunol. 2008. №122. S1–S84.
27. Wilson A.M., O’Byrne P.M., Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis // Am. J. Med. 2004. №116. Р. 338–344.
28. Wilson A.M., Orr L.C., Sims E.J., Lipworth B.J. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis // Clin. Exp. Allergy. 2001. №31. Р. 61–68.
29. Yanez A., Rodrigo G.J. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis // Ann. Allergy Asthma Immunol. 2002. №89. Р. 479–484.
Review
For citations:
Kozlov VS, Lazarevich lL. Allergic rhinitis according to evidence-based medicine. Meditsinskiy sovet = Medical Council. 2013;(2-2):98-102. (In Russ.) https://doi.org/10.21518/2079-701X-2013-2-2-98-102
Views:
489
Email this article 